1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine

ADVERTISEMENT

Identification

Molecular formula
C16H17ClN4
CAS Number
524680-58-8
IUPAC Name
1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine
Molecular Weight
301.79g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.3300g/cm3
Synonyms
172889-27-9
Interesting facts

Interesting Facts about 1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine

1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine is a notable compound in the realm of medicinal chemistry, particularly due to its potential applications in drug development. Here are some fascinating points about this compound:

  • Biological Activity: This compound belongs to a class of molecules known for their activity against various biological targets, which can lead to the development of novel therapeutic agents.
  • Structure Complexity: The dual ring structure of pyrazolo[3,4-d]pyrimidine contributes to its unique properties, making it an interesting subject for synthesizing derivatives to study structure-activity relationships.
  • Chlorine Substitution: The presence of the 4-chlorophenyl group not only influences the electronic properties of the compound but can also affect its interactions with biological targets, enhancing its potency or selectivity.
  • Synthetic Pathways: The synthesis of this compound can involve various organic reactions, showcasing the creativity of synthetic chemists. Techniques such as cyclization reactions could be pivotal in its formation.
  • Research Potential: Studies involving this compound can lead to insights into novel treatment modalities for diseases, particularly where modulation of specific pathways could be beneficial.

In summary, 1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine illustrates the convergence of complex chemistry and biological efficacy. Its multifaceted nature makes it an exemplary candidate for research, leading to potential advancements in therapeutic strategies.

ADVERTISEMENT